Squarepoint’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-68,050
Closed -$510K 3284
2025
Q1
$510K Buy
68,050
+51,516
+312% +$386K ﹤0.01% 1904
2024
Q4
$138K Buy
16,534
+4,384
+36% +$36.6K ﹤0.01% 2477
2024
Q3
$84.3K Buy
+12,150
New +$84.3K ﹤0.01% 2368
2024
Q2
Sell
-22,332
Closed -$130K 3069
2024
Q1
$130K Sell
22,332
-776
-3% -$4.5K ﹤0.01% 2201
2023
Q4
$151K Buy
23,108
+3,930
+20% +$25.7K ﹤0.01% 2204
2023
Q3
$92.4K Buy
19,178
+467
+2% +$2.25K ﹤0.01% 2262
2023
Q2
$95.4K Sell
18,711
-1,546
-8% -$7.89K ﹤0.01% 2219
2023
Q1
$111K Buy
+20,257
New +$111K ﹤0.01% 2007
2022
Q1
Sell
-10,202
Closed -$89K 2912
2021
Q4
$89K Buy
+10,202
New +$89K ﹤0.01% 2334
2021
Q2
Sell
-26,206
Closed -$241K 3100
2021
Q1
$241K Buy
+26,206
New +$241K ﹤0.01% 2038